As revenues for Eli Lilly’s popular weight loss drug Zepbound continue ... while interim CFO Gordon Brooks received $2.7 million. Anat Ashkenazi, who left the company to become CFO at Alphabet in July ...

In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares closed yesterday at $726.24.

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock is, again, testing multiyear lows. The $700 billion pharmaceutical giant ...

Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein ...

Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

Legalcategory· April 9, 2025 Former top lawyers at major companies decry Trump orders against law firms Former top legal executives at large companies including Microsoft , Intel and Eli Lilly ...

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), American Express Company (AXP) and Thermo Fisher Scientific Inc. (TMO), as well as ...

Alphabet's CFO Anat Ashkenazi shared those figures in February. On the same day, President Trump announced a temporary easing of tariffs on dozens of countries, while tightening trade measures ...

Alphabet's CFO Anat Ashkenazi had noted in February. On Wednesday, President Donald Trump said he would temporarily lower the high tariffs he imposed on dozens of countries, while increasing ...

But management is confident, as CFO Anat Ashkenazi said on the Q4 2024 earnings call. "We're pleased with the momentum we're seeing in AI innovation and monetization. We've been using AI to ...